Evidence map›Paper›PMID 28788066›Full record

ReviewNutrients2017

Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants.

Hans Demmelmair, Christine Prell, Niklas Timby, Bo Lönnerdal

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05119166 (International Milk Composition), which is not on this map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05119166 active not recruitingnot on this mapstarted 2019, after this paper: background citation

International Milk Composition (IMiC) Consortium

TypeobservationalSponsorUniversity of ManitobaRan2019 to 2026Enrolled1,000ConditionsInfant Growth, Maternal Health, Infant NutritionArmsVitamin B3, Azithromycin, Fortified food supplement
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 152 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Osteopontin: Its Properties, Recent Studies, and Potential Applications.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Lactoferrin: from the structure to the functional orchestration of iron homeostasis.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Review
  20. Lactoferrin, a Great Wall of host-defence?Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Hans DemmelmairDr. von Hauner Childrens Hospital, University of Munich Medical Center, D-80337 München, Germany. hans.demmelmair@med.uni-muenchen.de.
Christine PrellDr. von Hauner Childrens Hospital, University of Munich Medical Center, D-80337 München, Germany. Christine.Prell@med.uni-muenchen.de.
Niklas TimbyDepartment of Clinical Sciences, Pediatrics, Umeå University, SE-90187 Umeå, Sweden. niklas.timby@umu.se.
Bo LönnerdalDepartment of Nutrition, University of California, Davis, CA 95616, USA. bllonnerdal@ucdavis.edu.
Umeå University · SEUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The provision of essential and non-essential amino acids for breast-fed infants is the major function of milk proteins. In addition, breast-fed infants might benefit from bioactivities of milk proteins, which are exhibited in the intestine during the digestive phase and by absorption of intact proteins or derived peptides. For lactoferrin, osteopontin and milk fat globule membrane proteins/lipids, which have not until recently been included in substantial amounts in infant formulas, in vitro experiments and animal models provide a convincing base of evidence for bioactivities, which contribute to the protection of the infant from pathogens, improve nutrient absorption, support the development of the immune system and provide components for optimal neurodevelopment. Technologies have become available to obtain these compounds from cow´s milk and the bovine compounds also exhibit bioactivities in humans. Randomized clinical trials with experimental infant formulas incorporating lactoferrin, osteopontin, or milk fat globule membranes have already provided some evidence for clinical benefits. This review aims to compare findings from laboratory and animal experiments with outcomes of clinical studies. There is good justification from basic science and there are promising results from clinical studies for beneficial effects of lactoferrin, osteopontin and the milk fat globule membrane complex of proteins and lipids. Further studies should ideally be adequately powered to investigate effects on clinically relevant endpoints in healthy term infants.

Indexed as

GlycolipidsGlycoproteinsHumansInfantInfant FoodInfant Nutritional Physiological PhenomenaLactoferrinLipid DropletsOsteopontinGlycolipidsGlycoproteinsLactoferrinmilk fat globuleOsteopontinbioactive proteinshuman milklactoferrinmilk fat globule membraneosteopontin

Identifiers

PMID28788066
PMCPMC5579611
OpenAlexW2742147186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.